Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBMX2 encodes an RNA-binding protein localized in the nucleus, endoplasmic reticulum, and nucleolus, and is a core component of both the major and minor spliceosome complexes, contributing to pre-mRNA splicing including the processing of U12-type introns. Mutations in RBMX2, notably Alu element deletions, have been linked to bipolar disorder, syndromic X-linked intellectual disability, epilepsy, and hematological disorders such as X-linked thrombophilia. The protein plays a central role in brain development and function, and malfunction or structural variants may contribute to the risk and pathology of several neurological diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein, X-linked 2 (RBMX2).